Immune Design Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

Immune Design General Information

Description

Immune Design is a clinical-stage immunotherapy company. Its focus is next-generation in vivo methods intended to enable the body's immune system to fight diseases. The company's therapies have a broad potential approach across multiple therapeutic areas. Nevertheless, the company's target is oncology, and it is developing tumor-specific cytotoxic T cells to fight cancer. The main discoveries are CMB305 and G100, immuno-oncology approaches that are believed to address the shortcomings of existing oncological therapies.

Contact Information

Formerly Known As
Vaccsys, Vaccsys Inc
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1616 Eastlake Avenue East
  • Suite 310
  • Seattle, WA 98102
  • United States
+1 (206)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 1616 Eastlake Avenue East
  • Suite 310
  • Seattle, WA 98102
  • United States
+1 (206)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immune Design Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immune Design‘s full profile, request access.

Request a free trial

Immune Design Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Immune Design is a clinical-stage immunotherapy company. Its focus is next-generation in vivo methods intended to enable
Drug Discovery
Seattle, WA
50 As of 2018

New York, NY
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immune Design Competitors (63)

One of Immune Design’s 63 competitors is Lexeo Therapeutics, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lexeo Therapeutics Formerly VC-backed New York, NY
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Xenetic Biosciences Corporation Framingham, MA
ImCheck Therapeutics Formerly VC-backed Marseille, France
Sorrento Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 5 of 63 competitors. Get the full list »

Immune Design Patents

Immune Design Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3897700-A1 Pathogen-associated molecular pattern molecules and rna immunogenic compositions and methods of using the compositions for treating cancer Inactive 17-Dec-2018
EP-3897700-A4 Pathogen-associated molecular pattern molecules and rna immunogenic compositions and methods of using the compositions for treating cancer Inactive 17-Dec-2018
US-20220054611-A1 Pathogen-associated molecular pattern molecules and rna immunogenic compositions and methods of using the compositions for treating cancer Inactive 17-Dec-2018
WO-2020131656-A1 Pathogen-associated molecular pattern molecules and rna immunogenic compositions and methods of using the compositions for treating cancer Inactive 17-Dec-2018
WO-2018148180-A2 Materials and methods for identifying and treating cancer patients Inactive 07-Feb-2017 G01N33/6854
To view Immune Design’s complete patent history, request access »

Immune Design Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immune Design Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Immune Design‘s full profile, request access.

Request a free trial

Immune Design FAQs

  • When was Immune Design founded?

    Immune Design was founded in 2008.

  • Where is Immune Design headquartered?

    Immune Design is headquartered in Seattle, WA.

  • What is the size of Immune Design?

    Immune Design has 50 total employees.

  • What industry is Immune Design in?

    Immune Design’s primary industry is Drug Discovery.

  • Is Immune Design a private or public company?

    Immune Design is a Private company.

  • What is the current valuation of Immune Design?

    The current valuation of Immune Design is .

  • What is Immune Design’s current revenue?

    The current revenue for Immune Design is .

  • How much funding has Immune Design raised over time?

    Immune Design has raised $130M.

  • Who are Immune Design’s investors?

    Alta Partners, Altamont Pharmaceutical Holdings, Aventis, Osage University Partners, and ProQuest Investments are 5 of 9 investors who have invested in Immune Design.

  • Who are Immune Design’s competitors?

    Lexeo Therapeutics, CytomX Therapeutics, Xenetic Biosciences, ImCheck Therapeutics, and Sorrento Therapeutics are some of the 63 competitors of Immune Design.

  • When was Immune Design acquired?

    Immune Design was acquired on 02-Apr-2019.

  • Who acquired Immune Design?

    Immune Design was acquired by Merck & Co..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process